Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00337168

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Providence Cancer Center Anchorage, Alaska, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States

Stanford Cancer Center Stanford, California, United States

View all 91 locations

View Trial Details

Completed

Immunization Against Tumor Cells in Sezary Syndrome

NCT00099593

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsburgh Medical Center, Department of Dermatology Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma

NCT00064038

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: William Beaumont Hospital - Royal Oak Campus Royal Oak, Michigan, United States

Utah Cancer Specialists at UCS Cancer Center Salt Lake City, Utah, United States

View Trial Details

Completed

Effect of Denileukin Diftitox on Immune System in CTCL Patients

NCT00254332

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University of Pittsubrgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00109837

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Providence Saint Joseph Medical Center - Burbank Burbank, California, United States

Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States

Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States

Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States

View all 78 locations

View Trial Details

Completed

Investigation of Clofarabine in Acute Leukemias

NCT00098033

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blast Crisis, +25 more
Locations: Not specified

View Trial Details

Completed

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

NCT00741780

Conditions: Autologous Transplantation, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).

NCT00838357

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Front Line Mobilization, +20 more
Locations: Hôpital du Haut Lévêque Bordeaux, France

Hôpital Lyon Sud Lyon, France

Institut Paoli Calmettes Marseille, France

CHU Hotel-Dieu Université de Nantes Nantes, France

View all 26 locations

View Trial Details

Completed

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

NCT01738373

Conditions: Blood Protein Disorders, Bone Marrow / Autologous Transplants, Cardiovascular Diseases, +15 more
Locations: Marseille, France

View Trial Details

Completed

Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00694590

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

UTMD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions